Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician’s Experience Vidhatha ReddyShawn ThomasWilson Liao Commentary Open access 19 March 2020 Pages: 329 - 338
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times Nicholas D. BrownstoneQuinn G. ThibodeauxWilson Liao Commentary Open access 16 April 2020 Pages: 339 - 349
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence Jashin J. WuJoseph F. MerolaMark Lebwohl Review Open access 02 April 2020 Pages: 351 - 364
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations Stephanie ChanVidhatha ReddyWilson Liao Review Open access 06 April 2020 Pages: 365 - 386
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review Joanna NowaczykKarolina MakowskaLidia Rudnicka Review Open access 08 April 2020 Pages: 387 - 399
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma Alessia VillaniGabriella FabbrociniMassimiliano Scalvenzi Review Open access 15 April 2020 Pages: 401 - 412
Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross-Sectional Study Beata KowalewskaMateusz CybulskiElżbieta Krajewska-Kułak Original Research Open access 19 March 2020 Pages: 413 - 430
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials Craig LeonardiKristian ReichKim Papp Original Research Open access 21 March 2020 Pages: 431 - 447
Patient Education Programs in Pediatric Atopic Dermatitis: A Systematic Review of Randomized Controlled Trials and Meta-Analysis Mutong ZhaoYuan LiangXiuhua Ma Original Research Open access 21 March 2020 Pages: 449 - 464
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity Massimiliano ScalvenziMilena CappelloAlessia Villani Original Research Open access 02 April 2020 Pages: 465 - 468
Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study Rashmi SarkarSuneel VartakSujeet Narayan Charugulla Original Research Open access 10 April 2020 Pages: 469 - 479
Correction to: Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study Rashmi SarkarSuneel VartakSujeet Narayan Charugulla Correction Open access 29 April 2020 Pages: 481 - 481
Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study Fabio RinaldiAnna TrinkDaniela Pinto Original Research Open access 11 April 2020 Pages: 483 - 493
Evaluation of Accountability Measurement Tool in Patients with Psoriasis: A Validation Study Jennifer J. SuAbigail ClineSteven R. Feldman Original Research Open access 16 April 2020 Pages: 495 - 502
A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration Robert J. ConnorBarbara BlouwDavid W. Kang Original Research Open access 02 May 2020 Pages: 503 - 513
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Elisa MolinelliAnna CampanatiAnnamaria Offidani Brief Report Open access 27 April 2020 Pages: 515 - 521
Correction to: Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice Thrasyvoulos TzellosChristos C. Zouboulis Correction Open access 23 March 2020 Pages: 523 - 523